This bill could save money and make Medicaid more efficient | Opinion

Senate Bill 6024 and House Bill 2230, sponsored by Sen. Chris Gildon and Rep. Janice Zahn, would streamline monitoring and oversight of community residential 'supported living' services in Washington to reduce redundant state reviews and administrative burden. Supported living is roughly 99% Medicaid-funded, serves about 4,700 people statewide, and proponents—including Deirdre Farrison, state administrator at Ambitions of Washington—argue the measures would save taxpayer money, reduce disruption to clients after recent federal Medicaid cuts, and allow providers to reallocate staff time to direct care.

Analysis

Market structure: Passage of SB 6024/HB 2230 mostly benefits community-supported living providers (small nonprofits and private operators) via lower compliance burden and time freed for billable care; state agencies and third‑party compliance vendors lose recurring work. Expect modest margin improvement for operators (mid single‑digit percentage points over 12–24 months) and increased competitive parity that favors nimble local providers over large, compliance-heavy chains.

Risk assessment: Tail risks include bill rejection, federal CMS pushback, or increased fraud exposure that triggers federal clawbacks—each could reverse savings and widen state Medicaid costs; probability low-to-moderate but impact high. Near term (30–90 days) outcome hinges on legislative calendar and budget reconciliation; medium term (3–12 months) depends on implementation details (IT integration, inter-agency MOUs) which are hidden dependencies.

Trade implications: Tactical opportunities are small, idiosyncratic and municipal‑credit oriented — a passed bill should mildly tighten WA GO spreads by 5–20bp vs peers over 3–9 months and benefit select home‑health stocks. Use limited-size positions: overweight WA munis or buy 5–7yr WA GO paper, and take small long exposure to Medicaid-focused/public home‑health names while hedging with short-dated put protection or call spreads to cap downside.

Contrarian angles: Consensus underestimates M&A acceleration — streamlined oversight increases free cash flow visibility, making small providers attractive targets; conversely, reduced oversight can magnify fraud risk, producing episodic spikes in claims and regulatory reversals. Position sizing should assume either a binary legislative outcome or a 2–3 month implementation lag; set strict stop-losses and catalyst-based re-routes.

Key Decisions for Investors

• If the bills pass committee within 30 days, establish a 1–2% portfolio allocation to Washington 5–7yr GO bonds (buy direct WA issuances) targeting 5–20bp of spread compression vs comparable muni paper over 3–9 months; trim or exit if spread compression does not materialize within 90 days.
• Initiate a small (1% portfolio) long in Medicaid/home‑health equities: Amedisys (AMED) 1% and Centene (CNC) 0.5% for 3–9 months to capture margin/claims processing benefits; finance risk by buying 3-month OTM put protection (10–15% OTM) or use a 3-month call spread (+8%/+18%) to limit premium outlay.
• Implement a pair trade: overweight WA GO 5–7yr vs short CA GO 5–7yr by equal notionals (duration‑matched) sized to 1–2% portfolio risk; rationale: modest fiscal relief in WA could outperform larger, more stressed states over 3–12 months.
• Monitor legislative signals daily for 30–60 days (committee votes, budget language, governor statements, CMS guidance). If the bills stall or CMS issues stricter oversight rules, reduce health‑provider equity exposure by 50% within 5 trading days and reallocate to cash or short-duration munis.